Precision oncology startup 4baseCare has raised Rs 128 crore. This funding will expand its genomics labs globally and scale its AI platform, OncoTwin. The company aims to make precision oncology inclusive for under-represented populations. 4baseCare is also decentralising genomic testing infrastructure in India. This move brings advanced cancer diagnostics closer to patients and doctors.